+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia



Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia



Journal of Diabetes 8(4): 502-507



The effect of anemia in advanced chronic kidney disease (CKD) on morbidity and mortality is known. The aim of the present study was to assess the effect of mild anemia on hospitalization and 1-year all-cause mortality in type 2 diabetes mellitus (T2DM) patients with Stage 1 and 2 CKD. Hospitalized T2DM patients (n = 307) with a glomerular filtration rate ≥ 60 mL/min per 1.73 m(2) and urinary albumin excretion > 30 mg/24 h (Stage 1 and 2 CKD) were enrolled in the study and divided into two groups based on hemoglobin (Hb) concentrations: those with (mean [ ± SD] Hb 10.7 ± 0.7 g/dL) and without (mean Hb 13.3 ± 1.28 g/dL) anemia. There was no significant difference between patients with and without anemia in terms of age, gender, body mass index, HbA1c, and cardiovascular diseases. The mean length of hospitalization of the 130 anemic and 177 non-anemic patients was 4.3 ± 3.5 and 3.5 ± 1.9 days, respectively (P < 0.001). Twelve anemic patients died within 1 year, compared with three patients without anemia (9.2% vs 1.7%, respectively; P = 0.002). After adjusting for confounding variables, multivariate Cox regression analysis revealed that mild anemia was significantly associated with 1-year all-cause mortality (hazard ratio 2.15, 95% confidence interval 1.92-2.54; P = 0.033). Mild anemia may increase the length of hospitalization and was associated with 1-year all-cause mortality among hospitalized T2DM patients with Stage 1 and 2 CKD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058006796

Download citation: RISBibTeXText

PMID: 26040706

DOI: 10.1111/1753-0407.12318


Related references

Impact of anemia and chronic kidney disease on the risk of cardiovascular disease and all-cause mortality among diabetic patients. Beijing Da Xue Xue Bao. Yi Xue Ban 50(3): 495-500, 2018

Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality. Nihon Jinzo Gakkai Shi 53(1): 38-45, 2011

Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin. Journal of Diabetes 8(5): 712-719, 2017

Prevalence of anemia in patients with type II diabetes and mild to moderate chronic kidney disease and the impact of anti-RAS medications. Saudi Journal of Kidney Diseases and Transplantation 25(3): 552-557, 2014

Changes in Trace Elements During Early Stages of Chronic Kidney Disease in Type 2 Diabetic Patients. Biological Trace Element Research 186(2): 330-336, 2018

The Prevalence of the Risk Factors for Atherosclerosis among Type 2 Diabetic Patients Is Greater in the Progressive Stages of Chronic Kidney Disease. Nephron Extra 3(1): 66-72, 2013

Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis 210(2): 575-580, 2010

Phosphorus as an early marker of morbidity and mortality in type 2 chronic kidney disease diabetic patients. Journal of Diabetes and Its Complications 27(4): 328-332, 2014

Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease. International Urology and Nephrology 37(2): 395-402, 2005

Risk of mortality associated to chronic kidney disease in patients with type 2 diabetes mellitus: a 13-year follow-up. Nefrologia 35(5): 487-492, 2017

Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5. Advances in Chronic Kidney Disease 14(1): 105-112, 2007

A cross-sectional survey of chronic kidney disease and diabetic kidney disease in Japanese type 2 diabetic patients at four urban diabetes clinics. Internal Medicine 48(6): 411-414, 2009

Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate. Plos One 10(12): E0145505, 2016

Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. American Journal of Cardiology 92(11): 1300-1305, 2003

Chronic kidney disease and its association with mortality and hospitalization in Chinese nursing home older residents: a 3-year prospective cohort study. Journal of the American Medical Directors Association 13(9): 782-787, 2013